Our machine-learning algorithm designs compact, synthetic regulatory elements (promoters and enhancers) for gene therapies within a day, cutting design time from months to hours.
Therapies fail when promoters are generic. We design regulatory DNA tuned to the exact cell types you care about—neurons, astrocytes, microglia, and more—so your cargo expresses where it should, not everywhere it should not.
Cell Type SpecificCompact SizeHigh Strength
02
Transfecting Cells with DNA Plasmids
Once targets are clear, we help you move from sequence to transfection-ready plasmids. Our workflow keeps iteration tight so your lab spends less time cloning and more time validating biology.
Sequence-optimized regulatory modules
Plasmid maps and synthesis-ready formats
Iteration loops aligned to your assay schedule
03
Proof at program speed
Ranked designsready in a day.
Go from structured input to ranked designs, rationale, and synthesis-ready files in a day. Allowing your program timelines to compress without cutting specificity.
1
Day turnaround
< 14%
Current gene therapy success rate
22+
Institutional partners
Platform architecture
One synchronized output—four engineering constraints.
Cell-type specificity
Regulatory DNA tuned to the tissues and cell populations you specify—so expression lands where your program needs it, not everywhere else.
High activity
Designs emphasize robust, controllable expression aligned to your therapeutic window and the readouts your team will trust.
Payload independence
Modular elements that slot into diverse viral and non-viral backbones without forcing a ground-up redesign of your construct architecture.
Small size
Compact promoters and enhancers that preserve cargo capacity and stay friendly to synthesis and delivery constraints.
Our Advantage
Speed. Accuracy. Flexibility.
Speed
1 day
versus months of manual promoter engineering and literature triage.
Design→
Ranked candidates→
Synthesis-ready outputs
Accuracy
Models are trained to respect tissue context and manufacturing constraints—not just maximize in silico scores.
Transparency
We provide validation data for the patented promoters.
Highlight
Every design is traceable: inputs, constraints, and ranking rationale ship with the sequences.
Flexibility
AAV, LV, non-viral contexts; rodent and human; disease models and screens—one workflow adapts to your program.
Delivery & models
AAVLentivirusDNA onlyHumanMousePrimary cellsiPSC-derivedIn vivoEx vivo
The Process
HowOurAIAlgorithmWorks
See how our platform takes you from login to ranked promoter candidates in minutes.
Join academia and companies partnering with us.
Limited pilot slots for qualified academic labs and industry teams. Tell us your target profile and we will scope a trial that fits your timeline.
